MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Characteristics of Language Abnormalities in Multiple System Atrophy and Parkinson’s Disease

M. Subert, M. Novotny, P. Dusek, J. Klempir, J. Rusz, T. Tykalova (Prague, Czech Republic)

Meeting: 2024 International Congress

Abstract Number: 28

Keywords: Cognitive dysfunction, Multiple system atrophy(MSA): Clinical features, Parkinson’s

Category: Parkinsonism, Atypical: MSA

Objective: We characterized complex language profile and explore diagnostic potential of automated language analysis of natural spontaneous speech in differentiation between multiple system atrophy (MSA) and Parkinson’s disease (PD).

Background: Patients with synucleinopathies such as MSA and PD frequently display language abnormalities, however detailed language profile in MSA has never been investigated.

Method: A total of 39 participants with MSA compared to 39 age- and sex-matched de-novo untreated PD, and 39 age- and sex-matched healthy controls were recruited. The PD group was also matched to MSA by disease duration (mean 4.2, SD 1.6 years), estimated based on the self-reported manifestation of the first motor symptoms. All participants were guided to perform monologue on a topic of their preference lasting approximately 2 minutes. Each audio sample was transcribed and linguistically annotated using automatic speech recognition and natural language processing. A quantitative analysis was performed using 6 lexical and syntactic and 2 acoustic features. Results were compared with human-controlled analysis to assess robustness of the approach. Diagnostic accuracy was evaluated using sensitivity analysis.

Results: Despite similar disease duration, language abnormalities were generally more severe in MSA than in PD, leading to high diagnostic accuracy with an area under the curve of 0.81 (sensitivity 77%; specificity 74%). Compared to controls, MSA showed decreased grammatical component usage (p<0.001), more repetitive phrases (p=0.002), shorter sentences (p<0.001), reduced sentence development (p<0.001), slower articulation rate (p<0.001), and increased duration of pauses (p<0.001), whereas PD had only shorter sentences (p<0.001), reduced sentence development (p=0.003), and longer pauses (p=0.002). Only slower articulation rate was distinct for MSA while unchanged for PD. Despite relatively high severity of dysarthria in MSA, a strong reliability between manually and automatically computed results was achieved (Pearson’s r = 0.60-0.94).

Conclusion: Integrating automated language analysis could provide a cost-effective, time-efficient, and widely applicable novel tool to estimate the extent of cognitive impairment and early detect synucleinopathies with similar clinical manifestations.

To cite this abstract in AMA style:

M. Subert, M. Novotny, P. Dusek, J. Klempir, J. Rusz, T. Tykalova. Characteristics of Language Abnormalities in Multiple System Atrophy and Parkinson’s Disease [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/characteristics-of-language-abnormalities-in-multiple-system-atrophy-and-parkinsons-disease/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/characteristics-of-language-abnormalities-in-multiple-system-atrophy-and-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley